RNA Sequencing of Individual Versus Wastewater - SARS-CoV2

A Comparison Between Individual and Wastewater SARS-CoV2 RNA Sequencing

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05041764

Acronym

Cagablea

Enrollment

1409

Registered

2021-09-13

Start date

2020-10-01

Completion date

2020-11-01

Last updated

2021-09-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infection Viral

Brief summary

The aim is to compare the percentage of the different SARS-CoV2 lineages that are detected in wastewater samples with matched clinical samples. About 1,400 swab samples from patients living in Nice were tested by Biogroup between Oct 19th and Oct 23rd (Week 43 of 2020). The sequence of 81 PCR positive samples, corresponding to all samples that were unambiguously assigned to one of the wastewater catchment areas and their lineage was determined. These values were compared to values measured in wastewater.

Interventions

OTHERNO INTERVENTION

No INTERVENTION

Study design

Observational model

CASE_CONTROL

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* whole population tested in Nice during W43 of 2020

Exclusion criteria

* none

Design outcomes

Primary

Measure	Time frame	Description
SARS-CoV2 sequence	1 month	analyse of SARS-CoV2 sequence (in the case of positive samples)
RTqPCR result	1 month	positive ou negative result to SAR-Cov2

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026